MedPath

Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People

Not Applicable
Completed
Conditions
Sarcopenia
Registration Number
NCT01109628
Lead Sponsor
Wageningen University
Brief Summary

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Frail elderly individuals
  • Able to understand and perform the study procedures
Exclusion Criteria
  • Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol)
  • No recent history (within 2 years) of participating in any regular resistance exercise training program (general questionnaire)
  • Use of anti-coagulation medication (except of Acetyl Salicyl acid)
  • Renal insufficiency (eGFR <60 mL/min/1.73 m2)
  • Allergic or sensitive for milk proteins

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in skeletal muscle massBaseline, 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
Physical performanceBaseline, 3 months and 6 months
Blood parameters related to the outcome measuresBaseline, 3 months and 6 months
Dietary intakeBaseline, 3 months and 6 months
Blood pressureBaseline, 3 months and 6 months
Physical activityBaseline, 3 months and 6 months
Cognitive performanceBaseline and 6 months

Trial Locations

Locations (1)

Wageningen University

🇳🇱

Wageningen, Gelderland, Netherlands

Wageningen University
🇳🇱Wageningen, Gelderland, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.